Quick answer
An insurance policy requiring patients to first try less expensive medications before approving a more expensive one. Common for weight-loss GLP-1s, often requiring trials of phentermine, Saxenda, or older agents.
Full definition
Step therapy (also called 'fail first') is an insurance utilization management technique requiring patients to first try and fail (or have a contraindication to) less expensive medications before the plan will cover a more expensive option. For weight-loss GLP-1s, step therapy commonly requires a documented trial of phentermine, orlistat, naltrexone-bupropion (Contrave), or Saxenda (liraglutide) before approving Wegovy or Zepbound. Documentation must show inadequate efficacy or intolerance. Step therapy exception requests can sometimes be filed for medical contraindications.
Deep dive
Step Therapy: complete reference
Step therapy (also "fail-first therapy") is an insurance utilization-management protocol that requires patients to try and "fail" lower-tier medications before approving higher-tier alternatives. For GLP-1 medications, step therapy typically requires: documented trial of metformin (для diabetes patients), failed lifestyle intervention attempt (для weight management), и often trial of older anti-obesity medications (phentermine, naltrexone-bupropion, или orlistat) before approving GLP-1. Insurance plans use step therapy to control costs by encouraging less-expensive treatments first. Patient experience: prescriber writes для Wegovy, insurance denies, requires documentation of failed step therapy. To navigate: document any prior medication trials с dates + reasons for discontinuation, document lifestyle intervention attempts с structured programs, consider whether stepping through cheaper alternatives makes clinical sense vs appealing с medical necessity letter. Some prescribers can request "step therapy exception" — bypassing step requirements if medical contraindication to lower tiers exists.
- In practice
- Your insurance denies Wegovy saying "must try phentermine first." Your prescriber documents your previous phentermine trial that caused tachycardia, then resubmits — granted on appeal.
- Clinical context
- Step therapy is common для GLP-1 weight indications. Document failed prior treatments to facilitate appeals.
Medications
Step Therapy is most directly relevant to the following GLP-1 medications:
Related terms
- Prior Authorization (PA) — A health insurance requirement that a prescriber obtain plan approval before a covered drug will be …
- Formulary — The list of drugs an insurance plan covers, organized into tiers with different copays. GLP-1 RAs ty…
Continue learning
GLP1Zoom glossary is educational reference. Definitions are summary interpretations of clinical sources and not a substitute for prescribing-information detail. Full disclaimer.
References
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms и Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity(2015)
STEP-1 trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM)(2021)
SURMOUNT-1 trial: Tirzepatide Once Weekly для Treatment of Obesity (Jastreboff et al., NEJM)(2022)
SUSTAIN-6 trial: Semaglutide and Cardiovascular Outcomes (Marso et al., NEJM)(2016)
SURPASS-2 trial: Tirzepatide vs Semaglutide в Type 2 Diabetes (Frias et al., NEJM)(2021)
LEADER trial: Liraglutide and Cardiovascular Outcomes в T2D (Marso et al., NEJM)(2016)